Jens Hillengass MD, PhD | Roswell Park ...

Dr. Jens Hillengass, MD, PhD

Claim this profile

Roswell Park Cancer Institute

Expert in Multiple Myeloma
Studies Relapse
11 reported clinical trials
19 drugs studied

Area of expertise

1

Multiple Myeloma

Global Leader

Jens Hillengass, MD, PhD has run 11 trials for Multiple Myeloma. Some of their research focus areas include:

Stage IV
HLA-A positive
CD28 positive
2

Relapse

Jens Hillengass, MD, PhD has run 3 trials for Relapse. Some of their research focus areas include:

HLA-A positive
Stage IV

Affiliated Hospitals

Image of trial facility.

Roswell Park Cancer Institute

Image of trial facility.

Roswell Park

Clinical Trials Jens Hillengass, MD, PhD is currently running

More about Jens Hillengass, MD, PhD

Clinical Trial Related

3 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 1 Active Clinical Trial

Treatments Jens Hillengass, MD, PhD has experience with

  • Dexamethasone
  • Resistance Training
  • Lenalidomide
  • SVN53-67/M57-KLH Peptide Vaccine
  • Abatacept
  • Ixazomib Citrate

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Jens Hillengass, MD, PhD specialize in?

Is Jens Hillengass, MD, PhD currently recruiting for clinical trials?

Are there any treatments that Jens Hillengass, MD, PhD has studied deeply?

What is the best way to schedule an appointment with Jens Hillengass, MD, PhD?

What is the office address of Jens Hillengass, MD, PhD?

Is there any support for travel costs?